Supported by Vance Street Capital, PDC has finalized its acquisition of Resenex—a deal that will help the company advance fluid management solutions amongst its customers. Neither company disclosed the transaction’s terms.
Resenex was founded in 1981 by Pradip Choksi as an OEM of plastic fluid flow products, including check valves, including adjustable pressure relief valves, shielded connectors, and standard and tethered caps for medical and industrial applications. Resenex provides high-flow check valves and shielded connectors with tubing socket and barbed connectors for medical applications, including biopharmaceutical, infusion, wound care, surgical, and in-vitro diagnostics. The portfolio of products consists of off-the-shelf solutions using patented technology and customized products for more unique configurations. Resenex was founded in Chatsworth, Calif., and moved to Scottsdale, Ariz., in July 2024.
PDC is a contract manufacturer specializing in precision injection molding and value-added assembly for the medical device and life science markets. For more than 30 years, PDC has brought extensive expertise in working with complex materials like PEEK, COP, and COC. With a continued dedication to delivering products that meet stringent ISO 13485:2016 quality system standards, PDC’s focus on innovation, customer service, and advanced technology makes the firm an ideal micro molding partner. PDC is part of the Vance Street Capital portfolio.
